Drug application
AQUATENSEN (METHYCLOTHIAZIDE)
Drugs@FDA NDA 017364 · MEDPOINTE PHARM HLC
Key facts
| Drug name | AQUATENSEN |
|---|---|
| Active ingredients | METHYCLOTHIAZIDE |
| Application type | NDA |
| Application number | 017364 |
| Company | MEDPOINTE PHARM HLC |
| Dosage forms | TABLET, ORAL |
| Strength | 5MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Sep 7, 1977 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.